Eli Lilly and Company (LLY)
Eli Lilly and Company is an American multinational pharmaceutical company. It was founded in 1876 and is headquartered in Indianapolis, Indiana. The company develops, manufactures, and markets a wide range of pharmaceutical products, including prescription drugs and vaccines, for various medical conditions.
Company Info
| ISIN | US5324571083 |
|---|---|
| CUSIP | 532457108 |
| Sector | Healthcare |
| Industry | Drug Manufacturers—General |
Highlights
| Market Cap | $690.55B |
|---|---|
| EPS | $5.81 |
| PE Ratio | 125.01 |
| PEG Ratio | 1.43 |
| Revenue (TTM) | $34.12B |
| Gross Profit (TTM) | $21.91B |
| EBITDA (TTM) | $12.31B |
| Year Range | $367.60 - $800.78 |
| Target Price | $826.94 |
| Short % | 0.64% |
| Short Ratio | 1.82 |
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Popular comparisons: LLY vs. NVO, LLY vs. UNH, LLY vs. VOO, LLY vs. VRTX, LLY vs. XLV, LLY vs. DHR, LLY vs. DQ, LLY vs. AAPL, LLY vs. AGNG, LLY vs. LRCX
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Eli Lilly and Company, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Eli Lilly and Company had a return of 24.57% year-to-date (YTD) and 94.26% in the last 12 months. Over the past 10 years, Eli Lilly and Company had an annualized return of 31.29%, outperforming the S&P 500 benchmark which had an annualized return of 10.46%.
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | 24.57% | 5.84% |
| 1 month | -6.46% | -2.98% |
| 6 months | 28.06% | 22.02% |
| 1 year | 94.26% | 24.47% |
| 5 years (annualized) | 45.62% | 11.44% |
| 10 years (annualized) | 31.29% | 10.46% |
Monthly Returns Heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 10.75% | 16.94% | 3.22% | |||||||||
| 2023 | -3.08% | 3.13% | 6.90% | -1.37% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
Eli Lilly and Company(LLY)
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Eli Lilly and Company (LLY) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Eli Lilly and Company granted a 0.65% dividend yield in the last twelve months. The annual payout for that period amounted to $4.69 per share.
| Period | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $4.69 | $4.52 | $3.92 | $3.40 | $2.96 | $2.58 | $2.25 | $2.08 | $2.04 | $2.00 | $1.96 | $1.96 |
Dividend yield | 0.65% | 0.78% | 1.07% | 1.23% | 1.75% | 1.96% | 1.94% | 2.46% | 2.77% | 2.37% | 2.84% | 3.84% |
Monthly Dividends
The table displays the monthly dividend distributions for Eli Lilly and Company. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | $0.00 | $1.30 | $0.00 | |||||||||
| 2023 | $0.00 | $1.13 | $0.00 | $0.00 | $1.13 | $0.00 | $0.00 | $1.13 | $0.00 | $0.00 | $1.13 | $0.00 |
| 2022 | $0.00 | $0.98 | $0.00 | $0.00 | $0.98 | $0.00 | $0.00 | $0.98 | $0.00 | $0.00 | $0.98 | $0.00 |
| 2021 | $0.00 | $0.85 | $0.00 | $0.00 | $0.85 | $0.00 | $0.00 | $0.85 | $0.00 | $0.00 | $0.85 | $0.00 |
| 2020 | $0.00 | $0.74 | $0.00 | $0.00 | $0.74 | $0.00 | $0.00 | $0.74 | $0.00 | $0.00 | $0.74 | $0.00 |
| 2019 | $0.00 | $0.65 | $0.00 | $0.00 | $0.65 | $0.00 | $0.00 | $0.65 | $0.00 | $0.00 | $0.65 | $0.00 |
| 2018 | $0.00 | $0.56 | $0.00 | $0.00 | $0.56 | $0.00 | $0.00 | $0.56 | $0.00 | $0.00 | $0.56 | $0.00 |
| 2017 | $0.00 | $0.52 | $0.00 | $0.00 | $0.52 | $0.00 | $0.00 | $0.52 | $0.00 | $0.00 | $0.52 | $0.00 |
| 2016 | $0.00 | $0.51 | $0.00 | $0.00 | $0.51 | $0.00 | $0.00 | $0.51 | $0.00 | $0.00 | $0.51 | $0.00 |
| 2015 | $0.00 | $0.50 | $0.00 | $0.00 | $0.50 | $0.00 | $0.00 | $0.50 | $0.00 | $0.00 | $0.50 | $0.00 |
| 2014 | $0.00 | $0.49 | $0.00 | $0.00 | $0.49 | $0.00 | $0.00 | $0.49 | $0.00 | $0.00 | $0.49 | $0.00 |
| 2013 | $0.49 | $0.00 | $0.00 | $0.49 | $0.00 | $0.00 | $0.49 | $0.00 | $0.00 | $0.49 | $0.00 |
Dividend Yield & Payout
Dividend Yield
Payout Ratio
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the Eli Lilly and Company. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Eli Lilly and Company was 68.27%, occurring on Mar 5, 2009. Recovery took 1428 trading sessions.
The current Eli Lilly and Company drawdown is 8.51%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -68.27% | Aug 9, 2000 | 2154 | Mar 5, 2009 | 1428 | Nov 4, 2014 | 3582 |
| -60.84% | Jul 26, 1973 | 1051 | Sep 21, 1977 | 1443 | Jun 7, 1983 | 2494 |
| -46.4% | Jan 10, 1992 | 404 | Aug 13, 1993 | 408 | Mar 27, 1995 | 812 |
| -43.28% | Mar 8, 1999 | 254 | Mar 7, 2000 | 80 | Jun 29, 2000 | 334 |
| -40.74% | Sep 15, 1987 | 25 | Oct 19, 1987 | 353 | Mar 13, 1989 | 378 |
Volatility
Volatility Chart
The current Eli Lilly and Company volatility is 6.24%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Income Statement
| TTM | |
|---|---|
| Revenue | |
Total Revenue | 0.00 |
Cost Of Revenue | 0.00 |
Gross Profit | 0.00 |
| Operating Expenses | |
Selling, General & Admin Expenses | 0.00 |
R&D Expenses | 0.00 |
Total Operating Expenses | 0.00 |
| Income | |
Income Before Tax | 0.00 |
Operating Income | 0.00 |
EBIT | 0.00 |
Earnings From Continuing Operations | 0.00 |
Net Income | 0.00 |
Income Tax Expense | 0.00 |
Interest Expense | 0.00 |
Other Non-Operating Income (Expenses) | 0.00 |
Extraordinary Items | 0.00 |
Discontinued Operations | 0.00 |
Effect Of Accounting Charges | 0.00 |
Non Recurring | 0.00 |
Minority Interest | 0.00 |
Other Items | 0.00 |